|
1. Miles, EA, Banerjee, T, Calder, PC. The influence of different combinations of gamma-linolenic, stearidonic and eicosapentaenoic acids on the fatty acid composition of blood lipids and mononuclear cells in human volunteers. Prostaglandins Leukot. Essent. Fatty Acids. 2004 Jun;70(6):529-38.
2. Levin G, Duffin KL, Obukowicz MG, et al. Differential metabolism of dihomo-gamma-linolenic acid and arachidonic acid by cyclo-oxygenase-1 and cyclo-oxygenase-2: implications for cellular synthesis of prostaglandin E1 and prostaglandin E2. Biochem. J. 2002 Jul 15;365(Pt 2):489-96.
3. Barham, JB, Edens, MB, Fonteh, AN, et al. Addition of eicosapentaenoic acid to gamma-linolenic acid-supplemented diets prevents serum arachidonic acid accumulation in humans. J. Nutr. 2000 Aug;130(8):1925-31.
4. Johnson MM, Swan DD, Surette ME, et al. Dietary supplementation with gamma-linolenic acid alters fatty acid content and eicosanoid production in healthy humans. J Nutr. 1997 Aug;127(8):1435-44.
5. Ziboh VA, Fletcher MP. Dose-response effects of dietary gamma-linolenic acid-enriched oils on human polymorphonuclear-neutrophil biosynthesis of leukotriene B4. Am J Clin Nutr. 1992 Jan;55(1):39-45.
6. Chilton-Lopez, Surette ME, Swan DD, et al. Metabolism of gammalinolenic acid in human neutrophils. J Immunol. 1996 Apr 15;156(8):2941-7.
7. Umeda-Sawada R, Ogawa M, Igarashi O. The metabolism and N-6/N-3 ratio of essential fatty acids in rats : effect of dietary arachidonic acid and a mixture of sesame lignans (sesamin and episesamin). Lipids. 1998 Jun;33(6):567-72.
8. Shimizu S, Akimoto K, Shinmen Y, et al. Sesamin is a potent and specific inhibitor of delta-5-desaturase in polyunsaturated fatty acid biosynthesis. Lipids. 1991 Jul;26(7):512-6.
9. Fujiyama-Fujiwara, Y. Umeda-Sawada R, Kuzuyama M, Igarashi O. Effects of sesamin on the fatty acid composition of the liver of rats fed N-6 and N-3 fatty acid rich diet. J. Nutr. Sci. Vitaminol. (Tokyo) 1995 Apr;41(2):217-25.
10. Gu, JY, Wakizono Y, Tsujita A, et al. Effects of sesamin and alpha-tocopherol, individually or in combination, on the polyunsaturated fatty-acid metabolism, chemical mediator production, and immunoglobulin levels in Sprague-Dawley rats. Biosci. Biotechnol. Biochem. 1995 Dec; 59(12):2198-202.
11. Chavali SR, Zhong WW, Forse RA. Dietary alpha-linolenic acid increases TNF-alpha, and decreases IL-6, IL-10 in response to LPS: effects of sesamin on the delta-5 desaturation of omega6 and omega3 fatty acids in mice. Prostaglandins Leukot Essent Fatty Acids. 1998 Mar;58(3):185-91.
12. Akimoto K, Kitagawa Y, Akamatsu T, et al. Protective effects of sesamin against liver damage caused by alcohol or carbon tetrachloride in rodents. Ann Nutr Metab. 1993;37(4):218-24.
13. el Boustani S, Causse JE, Descomps B, et al. Direct in vivo characterization of delta 5 desaturase activity in humans by deuterium labeling: effect of insulin. Metabolism. 1989 Apr;38(4):315-21.
14. Pelikanova T, Kohout M, Base J, et al. Effect of acute hyperinsulinemia on fatty acid composition of serum lipids in non-insulin-dependent diabetics and healthy men. Clin Chim Acta. 1991 Dec 16;203(2-3):329-37.
15. van Doormaal JJ, Muskiet FA, van Ballegooie E, et al. The plasma and erythrocyte fatty acid composition of poorly controlled, insulin-dependent (type I) diabetic patients and the effect of improved metabolic control. Clin Chim Acta. 1984 Dec 29;144(2-3):203-12.
16. Medeiros LC, Liu YW, Park S, et al. Insulin, but not estrogen, correlated with indexes of desaturase function in obese women. Horm Metab Res. 1995 May;27(5):235-8.
17. Faas FH, Carter WJ. Altered microsomal phospholipid composition in the streptozotocin diabetic rat. Lipids. 1983 Apr;18(4):339-42.
18. Holman RT, Johnson SB, Gerrard JM, et al. Arachidonic acid deficiency in streptozotocin-induced diabetes. Proc Natl Acad Sci U S A. 1983 Apr;80(8):2375-9.
19. Huang YS, Horrobin DF, Manku MS, et al. Tissue phospholipid fatty acid composition in the diabetic rat. Lipids. 1984 May;19(5):367-70.
20. Dias VC, Parsons HG. Modulation in delta 9, delta 6, and delta 5 fatty acid desaturase activity in the human intestinal CaCo-2 cell line. J Lipid Res. 1995 Mar;36(3):552-63.
21. Gronn M, Christensen E, Hagve TA, et al. Effects of dietary purified eicosapentaenoic acid (20:5 (n-3)) and docosahexaenoic acid (22:6(n-3)) on fatty acid desaturation and oxidation in isolated rat liver cells. Biochim Biophys Acta. 1992 Apr 8;1125(1):35-43.
22. Christensen, J.H. N-3 fatty acids and the risk of sudden cardiac death. Emphasis on heart rate variability. Dan. Med. Bull. 2003 Nov;50(4): 347-67.
23. Browning LM. n-3 Polyunsaturated fatty acids, inflammation and obesity-related disease. Proc Nutr Soc. 2003 May;62(2):447-53.
24. Heller A, Koch T, Schmeck J, et al. Lipid mediators in inflammatory disorders. Drugs. 1998 Apr;55(4):487-96.
25. Horrobin DF. Loss of delta-6-desaturase activity as a key factor in aging. Med Hypotheses. 1981 Sep;7(9):1211-20.
26. Bolton-Smith C, Woodward M, Tavendale R. Evidence for age-related differences in the fatty acid composition of human adipose tissue, independent of diet. Eur J Clin Nutr. 1997 Sep;51(9):619-24.
27. Biagi PL, Bordoni A, Hrelia S, et al. Gamma-linolenic acid dietary supplementation can reverse the aging influence on rat liver microsome delta 6-desaturase activity. Biochim Biophys Acta. 1991 May 8;1083(2):187-92. |